Genetic Engineering Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Genetic Engineering Market By Product type (Cell Line , Animal Genome, Plant Genome), By Technique (Artificial Selection, Cloning, Gene Splicing, Others)By End User (Pharmaceutical companies, Biotechnology Companies, Academics, Clinical Research Organizations)By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Genetic Engineering Market size is estimated to reach USD 10.09 billion by 2027 and is poised to grow at a CAGR of 15.55% during the forecast period 2021-2027. The alteration of genes in an organism or species to improve its skills is known as genetic engineering. Pharmaceutical and biotechnology firms, as well as clinical research institutions, utilise the technology. Gene therapy is the most extensively utilised therapeutic method for cancer and other infectious disorders in medicine. Genetic engineering Market alludes to the set of technologies that directly manipulate on an organism’s genes, change the genetic makeup of cells and add one or more new traits that are not found in that organism. At the core of all life is the thing that we call DNA. It is in charge of the plenitude of life on this Earth and the motivation behind why we are how we are. The hereditary make-up of any creature is characterized by DNA. In nature, the genetic nature never stays settled. Biotech and pharma sectors dominating the Genetic Engineering Market industry owing to several applications in drug discovery and therapeutics. With the increase in the use of CRISPR and ZFN, companies are capitalizing on innovative researches focusing on the development of editing techniques. For example, the introduction of an initiative called the Artemisinin Project is planning to use synthetic biology to help treat malaria. Key strategies implemented by industry players include mergers and acquisitions, strategic collaborations for R&D outsourcing or manufacturing activities are driving the market growth of genome editing. For instance, Thermo Fisher acquired Life technologies in 2014, to create unbeatable leadership in life sciences, research, specialty diagnostics and applied markets.

Genetic Engineering Market

MARKET SUMMARY
-
15.55%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 15.55%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Genetic Engineering Market

  • The report on global Genetic Engineering Market gives historical, current and future market sizes (US$ Bn) on the basis of type, Technique, End User and region.
  • Genetic Engineering Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Thermo Fisher Scientific
  • Merck KGaA
  • New England Biolabs
  • Genscript Biotech Corporation
  • Lonza Group Ltd
  • Origene Technologies
  • Amgen Inc
  • Genentech, Inc
Market Dynamics

Genetic Engineering Market

Increasing prevalence of cancer and other genetic disorders, growing preference for personalized medicine, Increase in R&D expenditure and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and genetic engineering technologies, applications in various drug discovery processes are some of the factors propelling the growth of the genetic engineering market. Moreover, Global genetic engineering market may be hindered by stringent government regulations for approval to gene mutation projects, ethical issues, unavailability of gene based therapeutics in the market and lack of awareness among people regarding the safety of genetic interventions.


North-America Got Significant Share

Genetic Engineering Market

Geographically Genetic Engineering Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. The genetic engineering market is dominated by North America due to the strong growth trend in the pharmaceuticals and biotechnology industries and is followed by Europe. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the genetic engineering market due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems, the expansion of leading genetic engineering companies and increased R&D spending.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Genetic Engineering Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • Horizon Discovery Group Plc. (UK)
  • Transposagen Biopharmaceuticals Inc. (US)
  • New England Biolabs (U.S)
  • Genscript Biotech Corporation (US)
  • Lonza Group Ltd. (Switzerland)
  • Origene Technologies, Inc. (US)
  • Integrated DNA Technologies, Inc. (US)
  • Amgen Inc.(US)
  • Genentech, Inc. (US)
  • Sangamo Therapeutics, Inc. (US)

Description

Genetic Engineering Market size is estimated to reach USD 10.09 billion by 2027 and is poised to grow at a CAGR of 15.55% during the forecast period 2021-2027. The alteration of genes in an organism or species to improve its skills is known as genetic engineering. Pharmaceutical and biotechnology firms, as well as clinical research institutions, utilise the technology. Gene therapy is the most extensively utilised therapeutic method for cancer and other infectious disorders in medicine. Genetic engineering Market alludes to the set of technologies that directly manipulate on an organism’s genes, change the genetic makeup of cells and add one or more new traits that are not found in that organism. At the core of all life is the thing that we call DNA. It is in charge of the plenitude of life on this Earth and the motivation behind why we are how we are. The hereditary make-up of any creature is characterized by DNA. In nature, the genetic nature never stays settled. Biotech and pharma sectors dominating the Genetic Engineering Market industry owing to several applications in drug discovery and therapeutics. With the increase in the use of CRISPR and ZFN, companies are capitalizing on innovative researches focusing on the development of editing techniques. For example, the introduction of an initiative called the Artemisinin Project is planning to use synthetic biology to help treat malaria. Key strategies implemented by industry players include mergers and acquisitions, strategic collaborations for R&D outsourcing or manufacturing activities are driving the market growth of genome editing. For instance, Thermo Fisher acquired Life technologies in 2014, to create unbeatable leadership in life sciences, research, specialty diagnostics and applied markets.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX